Incidence and Pattern of Aminotransferase Elevation During Anti-Hypertensive Therapy With Angiotensin-II Receptor Blockers

Author:

Choi Won Joon1ORCID,Kim Gi-Ae2ORCID,Park Jaewon1ORCID,Jang Sangmi1ORCID,Jung Woo Jin1ORCID,Shim Jae-Jun2ORCID,Park Yewan2ORCID,Choi Gwang Hyeon1ORCID,Kim Jin-Wook1ORCID,Jeong Sook-Hyang1ORCID,Jang Eun Sun1ORCID

Affiliation:

1. Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.

2. Department of Internal Medicine, Kyung Hee University Medical Center, Seoul, Korea.

Publisher

Korean Academy of Medical Sciences

Subject

General Medicine

Reference23 articles.

1. Cardiovascular risk reduction in hypertension: angiotensin-converting enzyme inhibitors, angiotensin receptor blockers. Where are we up to?

2. Reports and Data. Angiotensin II receptor blockers market analysis, by type (Azilsartan, Candesartan, Eprosartan, Irbesartan, Losartan, Olmesartan, Telmisartan, Valsartan) by application (Hypertension, Cardiovascular risks) forecasts to 2028. Updated 2021. Accessed April 8, 2022. https://www.reportsanddata.com/report-detail/angiotensin-ii-receptor-blockers-market

3. The Korean Society of Hypertension - Hypertension Epidemiology Research Working Group. Korea hypertension fact sheet 2021. Updated 2021. Accessed April 8, 2022. https://www.koreanhypertension.org/reference/guide?mode=read&idno=4581

4. Losartan. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. Bethesda, MD, USA. National Institute of Diabetes and Digestive and Kidney Diseases. 2012-. Updated 2017. Accessed April 8, 2022. https://www.ncbi.nlm.nih.gov/books/NBK547842

5. Valsartan. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. Bethesda, MD, USA. National Institute of Diabetes and Digestive and Kidney Diseases. 2012-. Updated 2017. Accessed April 8, 2022. https://www.ncbi.nlm.nih.gov/books/NBK547944

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3